The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy
Status:
NOT_YET_RECRUITING
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn if Shenqi Yishen Granules works to treat IgA Nephropathy in adults. It will also learn about the safety of Shenqi Yishen Granules. The main questions it aims to answer are:
Does Shenqi Yishen Granules lower 24-hour urinary protein quantification of participants? What medical problems do participants have when taking Shenqi Yishen Granules? Researchers will compare Shenqi Yishen Granules to a placebo (a look-alike substance that contains no drug) to see if Shenqi Yishen Granules works to treat IgA Nephropathy.
Phase:
NA
Details
Lead Sponsor:
Keda Lu
Collaborators:
Affiliated Hospital of Jiaxing University First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine Hangzhou First People's Hospital, School of Medicine, Zhejiang Universiry Hangzhou Traditional Chinese Medicine Hospital Hangzhou Xiaoshan First People's Hospital Jiangsu Provincial Hospital of Traditional Chinese Medicine Red Cross Hospital, Hangzhou, China Shanghai 6th People's Hospital Shao Yifu Hospital of Zhejiang Medical University The First Affiliated Hospital of Zhejiang Chinese Medical University The Second Affiliated Hospital of Zhejiang Chinese Medical University Yuyao City Traditional Chinese Medicine Hospital Zhenhai District Traditional Chinese Medicine Hospital